Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | FGF23 | Q9GZV9 | 1/20 | 0.48 |
| ▸ | CFTR | P13569 | 1/20 | 0.48 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8705170 | 0.97 | PTGS2 (0.52) | PTGS2FGF23CFTRGOPCALDH1A1 | |
| SCHEMBL30144760 | 0.97 | PTGS2 (0.52) | PTGS2FGF23CFTRGOPCALDH1A1 | |
| SCHEMBL30877921 | 0.97 | PTGS2 (0.52) | PTGS2FGF23CFTRGOPCALDH1A1 | |
| SCHEMBL8705175 | 0.97 | PTGS2 (0.52) | PTGS2FGF23CFTRGOPCALDH1A1 | |
| SCHEMBL8518215 | 0.94 | PTGS2 (0.59) | PTGS2FGF23CFTRGOPCALDH1A1 | |
| SCHEMBL7212942 | 0.87 | ALDH1A1 (0.53) | PTGS2FGF23CFTRGOPCALDH1A1 | |
| SCHEMBL27874435 | 0.86 | KMT2A (0.46) | PTGS2FGF23CFTRGOPCALDH1A1 | |
| SCHEMBL5606620 | 0.85 | PTGS2 (0.53) | PTGS2FGF23ALDH1A1SLC6A2SLC6A4 | |
| SCHEMBL11823911 | 0.82 | PTGS2 (0.46) | PTGS2FGF23CFTRGOPCALDH1A1 | |
| SCHEMBL3243441 | 0.82 | FGF23 (0.46) | PTGS2FGF23CFTRGOPCALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5229979-A | — | — | None | — | — | JP | disclosed |
| US-20240114774-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-04-04 | — | — | US | disclosed |
| CN-117623944-A | Amine compound, light-emitting element comprising amine compound, and display device comprising light-emitting element | 三星显示有限公司 | 2024-03-01 | — | — | CN | disclosed |
| EP-0724566-B1 | 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 1998-10-07 | — | — | EP | disclosed |
| US-5663180-A | ANTIARTHRITIC, ANTIINFLAMMATORY AGENTS | G.D. SEARLE & CO. (US) | 1997-09-02 | — | — | US | disclosed |
| EP-0724566-A1 | 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-08-07 | — | — | EP | disclosed |
| US-5420287-A | 1,2 diarylcyclopentenyl compounds for the treatment of inflammation | G. D. SEARLE & CO. (US) | 1995-05-30 | — | — | US | disclosed |
| WO-1995011883-A1 | 1,2-DIARYLCYCLOPENTENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-05-04 | — | — | WO | disclosed |
| US-5344991-A | Sulfonyl or sulfamyl derivatives for treatment of arthritis and pain | G.D. SEARLE & CO. (US) | 1994-09-06 | — | — | US | disclosed |
| JP-H05229979-A | NEW BIPHENYLCYCLOHEXANE DERIVATIVE AND LIQUID CRYSTAL COMPOSITION | KANTO CHEM CO INC | 1993-09-07 | — | — | JP | disclosed |
| US-4401537-A | EPOXIDE, ONIUM CATALYST AND 3-GLYCIDOXYPROPYL/TRIETHOXYSILANE; CHEMICAL RESISTANCE; ADHESIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240114774-A1 | LIGHT EMITTING ELEMENT AND AMINE COMPOUND FOR THE SAME | CRY1, SLC1A2, CRY2 | PTGS2 3509/4885FGF23 1213/4885CFTR 4836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.